Potential markers of oxidative stress in stroke

Free Radical Biology and Medicine

Volumn 39, Issue 7, 2005, Pages 841-852

  Cherubini, Antonio ^a   Ruggiero, Carmelinda ^a   Polidori, M Cristina ^b   Mecocci, Patrizia ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antioxidant; Biomarker; Free radical; Oxidative stress; Stroke

Indexed keywords

8 HYDROXY 2 DEOXYGUANOSINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; FREE RADICAL; GUANOSINE DERIVATIVE; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; URIC ACID;

BRAIN DAMAGE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DNA DAMAGE; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 29144435788     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.06.025     Document Type: Review

References (100)

1. Caplan, L. R. Treatment of acute stroke: still struggling. JAMA 292:1883-1885; 2004.
2. Sarti, C.; Rastenyte, D.; Cepaitis, Z.; Tuomilehto, J. International trends in mortality from stroke, 1968 to 1994. Stroke 31: 1588-1601; 2000.
3. Ayala, C.; Greenlund, K. J.; Croft, J. B.; Keenan, N. L.; Donehoo, R. S., et al. Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995-1998. Am. J. Epidemiol. 154:1057-1063; 2001.
4. Lyden, P. D.; Zivin, J. A. Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc. Brain Metab. Rev. 5:1-16; 1993.
5. Sies, H. Oxidative stress: introductory remarks. In: Oxidative stress. London: Academic Press; 1985:1-8.
6. Cuzzocrea, S.; Riley, D. P.; Caputi, A. P.; Salvemini, D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53:135-159; 2001.
7. Lapchak, P. A.; Zivin, J. A. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator. Stroke 34:2013-2018; 2003.
8. Belayev, L.; Liu, Y.; Zhao, W.; Busto, R.; Ginsberg, M. D. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 32:553-560; 2001.
9. Huang, J.; Agus, D. B.; Winfree, C. J.; Kiss, S.; Mack, W. J., et al. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc. Natl. Acad. Sci. USA 98:11720-11724; 2001.
10. Yu, Z. F.; Bruce-Keller, A. J.; Goodman, Y.; Mattson, M. P. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J. Neurosci. Res. 53:613-625; 1998.
11. Alexandrova, M.; Bochev, P.; Markova, V.; Bechev, B.; Popova, M., et al. Dynamics of free radical processes in acute ischemic stroke: influence on neurological status and outcome. J. Clin. Neurosci. 11:501-506; 2004.
12. Schaller, B.; Graf, R. Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J. Cereb. Blood Flow Metab. 24:351-371; 2004.
13. Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 79:1431-1568; 1999.
14. Siesjo, B. K.; Agardh, C. D.; Bengtsson, F. Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1:165-211; 1989.
15. Choi, D. W.; Rothman, S. M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:171-182; 1990.
16. Lee, J. M.; Zipfel, G. J.; Choi, D. W. The changing landscape of ischaemic brain injury mechanisms. Nature 399:A7-A14; 1999.
17. Mander, P.; Borutaite, V.; Moncada, S.; Brown, G. C. Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. J. Neurosci. Res. 79:208-215; 2005.
18. Sims, N. R.; Anderson, M. F. Mitochondrial contributions to tissue damage in stroke. Neurochem. Int. 40:511-526; 2002.
19. Murakami, K.; Kondo, T.; Kawase, M.; Li, Y.; Sato, S., et al. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese Superoxide dismutase deficiency. J. Neurosci. 18:205-213; 1998.
20. Keller, J. N.; Kindy, M. S.; Holtsberg, F. W.; St Clair, D. K.; Yen, H. C., et al. Mitochondrial manganese Superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18:687-697; 1998.
21. Keynes, R. G.; Garthwaite, J. Nitric oxide and its role in ischaemic brain injury. Curr. Mol Med. 4:179-191; 2004.
22. Warner, D. S.; Sheng, H.; Batinic-Haberle, I. Oxidants, antioxidants and the ischemic brain. J. Exp. Biol 207:3221-3231; 2004.
23. Beckman, J. S. Peroxynitrite versus hydroxyl radical: the role of nitric oxide in superoxide-dependent cerebral injury. Ann. N. Y. Acad. Sci. 738:69-75; 1994.
24. Selim, M. H.; Ratan, R. R. The role of iron neurotoxicity in ischemic stroke. Ageing Res. Rev. 3:345-353; 2004.
25. Castillo, J.; Rama, R.; Davalos, A. Nitric oxide-related brain damage in acute ischemic stroke. Stroke 31:852-857; 2000.
26. Morimoto, T.; Globus, M. Y.; Busto, R.; Martinez, E.; Ginsberg, M. D. Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16:92-99; 1996.
27. Zini, I.; Tomasi, A.; Grimaldi, R.; Vannini, V.; Agnati, L. F. Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis. Neurosci. Lett. 138:279-282; 1992.
28. Yamato, M.; Egashira, T.; Utsumi, H. Application of in vivo ESR spectroscopy to measurement of cerebrovascular ROS generation in stroke. Free Radic. Biol. Med. 35:1619-1631; 2003.
29. Peters, O.; Back, T.; Lindauer, U.; Busch, C.; Megow, D., et al. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 18:196-205; 1998.
30. Fabian, R. H.; DeWitt, D. S.; Kent, T. A. In vivo detection of Superoxide anion production by the brain using a cytochrome c electrode. J. Cereb. Blood Flow Metab. 15:242-247; 1995.
31. Nath, F. P.; Jenkins, A.; Mendelow, A. D.; Graham, D. I.; Teasdale, G. M. Early hemodynamic changes in experimental intracerebral hemorrhage. J. Neurosurg. 65:697-703; 1986.
32. Qureshi, A. I.; Wilson, D. A.; Hanley, D. F.; Traystman, R. J. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology 52:266-272; 1999.
33. Xue, M.; Del Bigio, M. R. Intracortical hemorrhage injury in rats: relationship between blood fractions and brain cell death. Stroke 31:1721-1727; 2000.
34. Hickenbottom, S. L.; Grotta, J. C.; Strong, R.; Denner, L. A.; Aronowski, J. Nuclear factor-kappaB and cell death after experimental intracerebral hemorrhage in rats. Stroke 30:2472-2477; 1999.
35. Wu, J.; Hua, Y.; Keep, R. F.; Schallert, T.; Hoff, J. T., et al. Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res. 953:45-52; 2002.
36. Pluta, R. M. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol. Ther. 105:23-56; 2005.
37. Group, B. D. W. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69:89-95; 2001.
38. Offord, E.; van Poppel, G.; Tyrrell, R. Markers of oxidative damage and antioxidant protection: current status and relevance to disease. Free Radic. Res. 33:5-19; 2000.
39. Griffiths, H. R.; Moller, L.; Bartosz, G.; Bast, A.; Bertoni-Freddari, C., et al. Biomarkers. Mol. Aspects Med. 23:101-208; 2002.
40. Lewin, D. A.; Weiner, M. P. Molecular biomarkers in drug development. Drug Discov. Today 9:976-983; 2004.
41. Blumberg, J. Use of biomarkers of oxidative stress in research studies. J. Nutr. 134:3188-3189; 2004.
42. Braughler, J. M.; Hall, E. D. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic. Biol. Med. 6: 289-2301; 1989.
43. Roberts, L. J.; Morrow, J. D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 28:505-513; 2000.
44. Re, G.; Azzimondi, G.; Lanzarini, C.; Bassein, L.; Vaona, I., et al. Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism. Eur. J. Emerg. Med. 4:5-9; 1997.
45. Belch, J.; McLaren, M.; Hanslip, J.; Hill, A.; Davidson, D. The white blood cell and plasma fibrinogen in thrombotic stroke: a significant correlation. Int. Angiol. 17:120-124; 1998.
46. Bolokadze, N.; Lobjanidze, I.; Momtselidze, N.; Solomonia, R.; Shakarishvili, R., et al. Blood rheological properties and lipid peroxidation in cerebral and systemic circulation of neurocritical patients. Clin. Hemorheol. Microcirc. 30:99-105; 2004.
47. Sharpe, P. C.; Mulholland, C.; Trinick, T. Ascorbate and malondialdehyde in stroke patients. Ir. J. Med. Sci. 163:488-491; 1994.
48. Demirkaya, S.; Topcuoglu, M. A.; Aydin, A.; Ulas, U. H.; Isimer, A. I., et al. Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur. J. Neurol. 8:43-51; 2001.
49. Polidori, M. C.; Cherubini, A.; Stahl, W.; Senin, U.; Sies, H., et al. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic. Res. 36:265-268; 2002.
50. Gariballa, S. E.; Hutchin, T. P.; Sinclair, A. J. Antioxidant capacity after acute ischaemic stroke. Qjm 95:685-690; 2002.
51. Cano, C. P.; Bermudez, V. P.; Atencio, H. E.; Medina, M. T.; Anilsa, A., et al. Increased serum malondialdehyde and decreased nitric oxide within 24 hours of thrombotic stroke onset. Am. J. Ther. 10:473-476; 2003.
52. Janero, D. R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol Med. 9:515-540; 1990.
53. Bowen, P. E.; Mobarhan, S. Evidence from cancer intervention and biomarker studies and the development of biochemical markers. Am. J. Clin. Nutr. 62:1403-1409; 1995.
54. Esterbauer, H. Estimation of peroxidative damage. A critical review. Pathol. Biol. (Paris) 44:25-28; 1996.
55. Halliwell, B.; Chirico, S. Lipid peroxidation: its mechanism, measurement, and significance. Am. J. Clin. Nutr. 57:715-724; discussion 724-725; 1993.
56. Yeo, H. C.; Helbock, H. J.; Chyu, D. W.; Ames, B. N. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal. Biochem. 220:391-396; 1994.
57. Liu, J.; Yeo, H. C.; Doniger, S. J.; Ames, B. N. Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal. Biochem. 245:161-166; 1997.
58. Cighetti, G.; Debiasi, S.; Paroni, R.; Allevi, P. Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. Anal. Biochem. 266:222-229; 1999.
59. Polidori, M. C.; Frei, B.; Cherubini, A.; Nelles, G.; Rordorf, G., et al. Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic. Biol Med. 25:561-567; 1998.
60. Uno, M.; Kitazato, K. T.; Nishi, K.; Itabe, H.; Nagahiro, S. Raised plasma oxidised LDL in acute cerebral infarction. J. Neurol. Neurosurg. Psychiatry 74:312-316; 2003.
61. Shie, F. S.; Neely, M. D.; Maezawa, I.; Wu, H.; Olson, S. J., et al. Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion. Am. J. Pathol 164:1173-1181; 2004.
62. Fam, S. S.; Morrow, J. D. The isoprostanes: unique products of arachidonic acid oxidation-A review. Curr. Med. Chem. 10: 1723-1740; 2003.
63. van Kooten, F.; Ciabattoni, G.; Patrono, C.; Dippel, D. W.; Koudstaal, P. J. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke 28:1557-1563; 1997.
64. Sanchez-Moreno, C.; Dashe, J. F.; Scott, T.; Thaler, D.; Folstein, M. F., et al. Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 35:163-168; 2004.
65. Polidori, M. C., Praticò, D., Ingegni, T., Spazzafumo, L., Del Sindaco, P., Cecchetti, R., Rokach, J., Ricci, S., Cherubini, A., Stahl, W., Sies, H., Senin, U., Mecocci, P., for the AVASAS study group. Effects of vitamin C and aspirin in ischemic stroke-related oxidative stress: results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) study. Biofactors 2005 (in press).
66. Cui, J.; Holmes, E. H.; Greene, T. G.; Liu, P. K. Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain. FASEB J. 14:955-967; 2000.
67. Liu, H.; Uno, M.; Kitazato, K. T.; Suzue, A.; Manabe, S., et al. Peripheral oxidative biomarkers constitute a valuable indicator of the severity of oxidative brain damage in acute cerebral infarction. Brain Res. 1025:43-50; 2004.
68. Nagayama, T.; Lan, J.; Henshall, D. C.; Chen, D.; O'Horo, C., et al. Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J. Neurochem. 75:1716-1728; 2000.
69. Collins, A. R.; Cadet, J.; Moller, L.; Poulsen, H. E.; Vina, J. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells? Arch. Biochem. Biophys. 423:57-65; 2004.
70. Jaruga, P.; Speina, E.; Gackowski, D.; Tudek, B.; Olinski, R. Endogenous oxidative DNA base modifications analysed with repair enzymes and GC/MS technique. Nucleic Acids Res. 28:E16; 2000.
71. Dizdaroglu, M.; Jaruga, P.; Birincioglu, M.; Rodriguez, H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol Med. 32:1102-1115; 2002.
72. Chang, C. Y.; Lai, Y. C.; Cheng, T. J.; Lau, M. T.; Hu, M. L. Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radic. Res. 28:15-24; 1998.
73. Butterfield, D. A.; Kanski, J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev. 122:945-962; 2001.
74. Fukuyama, N.; Takizawa, S.; Ishida, H.; Hoshiai, K.; Shinohara, Y., et al. Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region. J. Cereb. Blood Flow Metab. 18:123-129; 1998.
75. Hall, A. C.; Lucas, F. R.; Salinas, P. C. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100:525-535; 2000.
76. Polidori, M. C.; Mattioli, P.; Aldred, S.; Cecchetti, R.; Stahl, W., et al. Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement. Geriatr. Cogn. Disord. 18:265-270; 2004.
77. Carty, J. L.; Bevan, R.; Waller, H.; Mistry, N.; Cooke, M., et al. The effects of vitamin C supplementation on protein oxidation in healthy volunteers. Biochem. Biophys. Res. Commun. 273: 729-735; 2000.
78. Polidori, M. C.; Stahl, W.; Eichler, O.; Niestroj, I.; Sies, H. Profiles of antioxidants in human plasma. Free Radic. Biol. Med. 30:456-462; 2001.
79. Martin, A.; Cherubini, A.; Andres-Lacueva, C.; Paniagua, M.; Joseph, J. Effects of fruits and vegetables on levels of vitamins E and C in the brain and their association with cognitive performance. J. Nutr. Health. Aging 6:392-404; 2002.
80. Lin, S. N.; Horning, E. C. Concurrent determination of alphatocopherol and free fatty acids in human plasma by glass open tubular capillary column gas chromatography. J. Chromatogr. 112: 465-482; 1975.
81. Hume, R.; Vallance, B. D.; Muir, M. M. Ascorbate status and fibrinogen concentrations after cerebrovascular accident. J. Clin. Pathol 35:195-199; 1982.
82. El Kossi, M. M.; Zakhary, M. M. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 31:1889-1892; 2000.
83. Leppala, J. M.; Virtamo, J.; Fogelholm, R.; Albanes, D.; Heinonen, O. P. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke 30:2535-2540; 1999.
84. Barer, D.; Leibowitz, R.; Ebrahim, S.; Pengally, D.; Neale, R. Vitamin C status and other nutritional indices in patients with stroke and other acute illnesses: a case-control study. J. Clin. Epidemiol. 42:625-631; 1989.
85. De Keyser, J.; De Klippel, N.; Merkx, H.; Vervaeck, M.; Herroelen, L. Serum concentrations of vitamins A and E and early outcome after ischaemic stroke. Lancet 339:1562-1565; 1992.
86. Sudha, K.; Rao, A. V.; Rao, S.; Rao, A. Lipid peroxidation, hemolysis and antioxidant enzymes of erythrocytes in stroke. J. Indian, Physiol. Pharmacol 48:199-205; 2004.
87. Leinonen, J. S.; Ahonen, J. P.; Lonnrot, K.; Jehkonen, M.; Dastidar, P., et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 31:33-39; 2000.
88. Weir, C. J.; Muir, S. W.; Walters, M. R.; Lees, K. R. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34:1951-1956; 2003.
89. Chamorro, A.; Obach, V.; Cervera, A.; Revilla, M.; Deulofeu, R., et al. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 33:1048-1052; 2002.
90. Okado-Matsumoto, A.; Fridovich, I. Subcellular distribution of Superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J. Biol. Chem. 276:38388-38393; 2001.
91. Marklund, S. L. Extracellular Superoxide dismutase in human tissues and human cell lines. J. Clin. Invest. 74:1398-1403; 1984.
92. Adachi, T.; Nakamura, M.; Yamada, H.; Futenma, A.; Kato, K., et al. Quantitative and qualitative changes of extracellular-superoxide dismutase in patients with various diseases. Clin. Chim. Acta 229:123-131; 1994.
93. Strand, T.; Marklund, S. L. Release of Superoxide dismutase into cerebrospinal fluid as a marker of brain lesion in acute cerebral infarction. Stroke 23:515-518; 1992.
94. Gruener, N.; Gross, B.; Gozlan, O.; Barak, M. Increase in Superoxide dismutase after cerebrovascular accident. Life. Sci. 54: 711-713; 1994.
95. Imre, S. G.; Fekete, I.; Farkas, T. Increased proportion of docosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke 25:2416-2420; 1994.
96. Spranger, M.; Krempien, S.; Schwab, S.; Donneberg, S.; Hacke, W. Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Correlation with clinical course and infarct size. Stroke 28:2425-2428; 1997.
97. Cherubini, A.; Polidori, M. C.; Bregnocchi, M.; Pezzuto, S.; Cecchetti, R., et al. Antioxidant profile and early outcome in stroke patients. Stroke 31:2295-2300; 2000.
98. Zimmermann, C.; Winnefeld, K.; Streck, S.; Roskos, M.; Haberl, R. L. Antioxidant status in acute stroke patients and patients at stroke risk. Eur. Neurol 51:157-161; 2004.
99. Polidori, M. C.; Mecocci, P.; Frei, B. Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke 32:898-902; 2001.
100. Dotan, Y.; Lichtenberg, D.; Pinchuk, I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog. Lipid. Res. 43:200-227; 2004.